Emory University a
line a aa line
  a

August 21, 2012

  a

Research Extras

Find out more about the redesignation and funding of three major centers at Emory:

The National Cancer Institute renewed the Winship Cancer Institute's designation as an NCI-Designated Cancer Center for five years.

The National Institutes of Health (NIH) awarded $30.7 million over five years for the renewal of the Atlanta Clinical & Translational Science Institute.

The Emory Center for AIDS Research (CFAR) received redesignation as an NIH CFAR site, with five-year funding of more than $9 million.

Learn more about a new Integrated Cellular imaging (ICI) Core, a partnership between the Winship Cancer Institute and Emory School of Medicine offering 22 cellular imaging services in one of the largest imaging cores in the Southeast.

View The Science Coalition's new Innovators initiative, featuring federally funded scientists. The current website includes Emory researchers Jing Chen and Michael Frankel.

 

 

 

a
       
a a
Tubes with infrared sensors track flies' sleep behavior
line
       

Musical Training Helps Prevent Cognitive Decline in Later Life
Musicians with at least 10 years of instrumental training remain cognitively sharp in advanced age, new research shows. Benefits include verbal and nonverbal brain functions and memory. Music lessons at an early age promote development of working memory, and sustained musical activity predicts non-verbal cognitive abilities. The results were found regardless of educational level. Read more...

           
a a
The Emory Cancer Genomics Center Team
         
 

Overcoming 'Original Sin' in Flu Vaccine Research
The influenza virus is a tricky vaccine target because flu strains mutate their DNA and shift within different host species, such as pigs and birds. The immune response is sometimes dampened by an obstacle called "original antigenic sin" (OAS) in which antibodies respond to an earlier viral exposure rather than the current one. Now a vaccine additive, or adjuvant, has been found to help overcome OAS. Read more..

     
           
a a

line
         
 

New Clinical Trials Provide Hope for Children and Families with Fragile X Syndrome
Two decades after Emory scientists led the discovery of the gene responsible for fragile X syndrome, three multi-center clinical trials are targeting the molecular changes caused by inactivation of the gene. Physicians and scientists hope these studies will determine whether learning and behavior deficits can improve with drug therapy. Read more...

     
         
a a
Peng Jin
line

         
 

Blood Test for Alzheimer's Gaining Ground
Researchers have found a group of four proteins in the blood that were significantly different in patients with mild cognitive impairment and Alzheimer’s compared to healthy volunteers in a clinical study. This kind of sensitive signal could help physicians with early diagnosis, but more specific information is needed, and additional studies will continue in larger groups of patients. Read more...

     
           
a a
       
 

Modified tPA Could Be Effective Stroke Treatment Without Bleeding Risk
Tissue plasminogen activator (tPA) was introduced as a clot-busting treatment for acute stroke in the 1990s, but many people do not receive tPA because of time constraints or the risk of deadly hemorrhage. Researchers have found that even when its clot-dissolving powers are removed, tPA can still protect brain cells from the loss of oxygen and glucose during a stroke without increasing bleeding risk. Read more...

     
           
Woodruff Health Sciences Center
a a

Link to the Current Issue More Research News Archives Contact Us Holly Korshun David Stephens